Почетна › Карцином ендометријума › Оклахома › Oklahoma City
Kliničke studije za Карцином ендометријума u gradu Oklahoma City, OK
28 studija za Карцином ендометријума traži učesnike na lokacijama u gradu Oklahoma City i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Тражи се учесникФаза 2
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
Тражи се учесникФаза 1
- University of Oklahoma Health Sciences Center, Oklahoma City
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Тражи се учесникФаза 2
- University of Oklahoma Health Sciences Center, Oklahoma City
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Тражи се учесникФаза 2
- University of Oklahoma Health Sciences Center, Oklahoma City
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
Тражи се учесникФаза 3
- Peggy & Charles Stephenson Oklahoma Cancer Center, Oklahoma City
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Тражи се учесникФаза 3
- University of Oklahoma Health Sciences Center, Stephenson Cancer Center ( Site 6012), Oklahoma City
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Тражи се учесникФаза 3
- University of Oklahoma Health Sciences Center, Oklahoma City
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Тражи се учесникФаза 1/2
- University of Oklahoma - Health Sciences Center, Oklahoma City
Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic
Тражи се учесникФаза 1
- OU Health Stephenson Cancer Center, Oklahoma City
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- Stephenson Cancer Center, Oklahoma City
ALPINE: Maintenance Letrozole/Abemaciclib
Тражи се учесникФаза 2
- OU Health Stephenson Cancer Center, Oklahoma City
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Тражи се учесникФаза 3
- Research Site, Oklahoma City
Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer
Тражи се учесникФаза 1
- University of Oklahoma, Oklahoma City
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Тражи се учесникФаза 1
- OU Health Stephenson Cancer Center, Oklahoma City
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Тражи се учесникФаза 1/2
- University of Oklahoma, Oklahoma City
Study of AVZO-021 in Patients With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- Avenzo Therapeutics Recruiting Site, Oklahoma City
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
Тражи се учесникФаза 1/2
- Stephenson Cancer Center, Oklahoma City
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Тражи се учесникФаза 1/2
- University of Oklahoma, Oklahoma City
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
Тражи се учесникФаза 2
- Stephenson Cancer Center at OU Health, Oklahoma City
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Тражи се учесникФаза 1
- Normunity Investigational Site, Oklahoma City
A Study of DM002 in Patients With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- University of Oklahoma Health Sciences Center, Oklahoma City
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Тражи се учесникФаза 1/2
- Stephenson Cancer Center Oklahoma University Health, Oklahoma City
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
Тражи се учесникОпсервациона студија
- Mercy Hospital - OKC, Oklahoma City
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
Тражи се учесникФаза 1/2
- University of Oklahoma Health Stephenson Cancer Center, Oklahoma City
Uterine Preservation Via Lifestyle Transformation
Тражи се учесникФаза 2
- University of Oklahoma, Oklahoma City
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Тражи се учесникФаза 1
- Dren Investigational Site, Oklahoma City
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
Тражи се учесникФаза 2
- Oklahoma University Stephenson Cancer Center, Oklahoma City
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
Тражи се учесникФаза 2
- University of Oklahoma, Oklahoma City
Studije za Карцином ендометријума u drugim gradovima
- Houston, TX69 студија
- New York City, NY54 студија
- Boston, MA51 студија
- Arlington, VA41 студија
- Nashville, TN38 студија
- Los Angeles, CA35 студија
- St. Louis, MO29 студија
- Philadelphia, PA29 студија
- San Antonio, TX27 студија
- Queens, NY26 студија
- Dallas, TX25 студија
- Pittsburgh, PA24 студија
Ostale studije u gradu Oklahoma City
- Немалоклетни карцином плућа32 студија
- Рак јајника29 студија
- Колоректални карцином22 студија
- Рак простате22 студија
- Рак плућа20 студија
- Рак дојке18 студија
- Метастатски карцином17 студија
- Akutna mijeloidna leukemija15 студија
- Рак (све врсте)15 студија
- Плоскоклеточни карцином главе и врата14 студија
- Рак бешике11 студија
- Рак панкреаса11 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.